NEW DELHI: India moved closer to the rollout of its vaccination plan against Covid-19 with the subject expert committee of the drug regulator on Friday recommending emergency-use authorisation (EUA) for Serum Institute of India’s “Covishield”, developed by Oxford University and AstraZeneca. Sources said the SEC’s...